Role of Circulating Pyrophosphate as a Biomarker of Mediacalcinosis in Type 2 Diabetic Patients
NCT07005986
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Type 2 Diabetes Patients
Interventions
DIAGNOSTIC_TEST:
Plasmatic PPi level
Sponsor
Centre Hospitalier Universitaire de Nice